Drugs Information: Ocrelizumab
Basic Information
|
||
| ID | DDInter1321 | |
| Drug Type | biotech | |
| Molecular Formula | C6494H9978N1718O2014S46 | |
| Molecular Weight | - | |
| Description | Ocrelizumab is a CD20 specific monoclonal antibody used to treat relapsing remitting multiple sclerosis. | |
| ATC Classification | L04AA36 | |
| IUPAC Name | None | |
| InChI | None | |
| InChI Key | None | |
| Canonical SMILES | None | |
| Useful Links | DrugBank | |
Interactions with Ocrelizumab
| Severity level | ID | Name | Mechanism | Detail |
|---|